958. A Novel Approach to Proliferate Factor IX-Producing Hepatocytes Using Urokinase-Type Plasminogen Activator Transgenic SCID Mice for Establishment of Cell-Based Therapy of Hemophilia B [PDF]
openalex +1 more source
Case Report: Severe hemophilia B patient with inhibitor and anaphylaxis reaction to FIX, successfully managed with concizumab prophylaxis therapy. [PDF]
Bonetti E +9 more
europepmc +1 more source
European Journal of Haematology, Volume 115, Issue 6, Page 618-619, December 2025.
wiley +1 more source
Lipid Nanoparticle-Mediated Liver-Specific Gene Therapy for Hemophilia B. [PDF]
Lohchania B +5 more
europepmc +1 more source
Some MSM Blood Donors Move from a Lifetime Deferral to a One Year Ban “Finally” or “Not Good Enough”? [PDF]
Printz, Heather
core +1 more source
Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review [PDF]
Mark T. Reding +11 more
openalex +1 more source
Relationship between Dose, Factor IX Activity Levels and Bleeding Probability for rIX-FP Prophylaxis in Hemophilia B: A Repeated Time-to-Event Analysis. [PDF]
Koopman SF +3 more
europepmc +1 more source
Retroperitoneal hematoma complicated with colocutaneous fistula in a case of severe hemophilia B
Haydar Zengin +3 more
openalex +1 more source
Development of iPSC-derived FIX-secreting hepatocyte sheet as a novel treatment tool for hemophilia B treatment. [PDF]
Bayarsaikhan D +5 more
europepmc +1 more source

